Stocktoria

Revolution Medicines, Inc. RVMD

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-02-13 · LEI

Revolution Medicines, Inc. statistics & valuation

Market cap$38.7B
P / B23.7×
Return on equity-69.3%
Return on capital-57.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-108.20% -257.50% -639.70% -730.00% -4207.10% 2019202020212022202320242025
Return on equity (%)
-22.80% -31.00% -36.30% -23.90% -26.50% -69.30% 2019202020212022202320242025
Shares outstanding
3.3M 66.6M 74.1M 90.4M 164.7M 185.9M 197.0M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-21.60% -19.10% -25.40% -30.60% -21.20% -23.50% -48.00% 2019202020212022202320242025
Free cash flow margin (%)
-104.30% -239.60% -523.00% -664.80% -3094.10% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$2.01 -$2.57 -$3.08 -$3.86 -$3.58 -$5.95 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin——-4207.1%-730.0%-639.7%-257.5%-108.2%
Net margin——-3768.3%-703.0%-636.6%-251.6%-95.2%
FCF margin——-3094.1%-664.8%-523.0%-239.6%-104.3%
Return on assets-48.0%-23.5%-21.2%-30.6%-25.4%-19.1%-21.6%
Return on equity-69.3%-26.5%-23.9%-36.3%-31.0%-22.8%31.2%
Current ratio7.1414.2013.0610.659.779.633.11

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.